MARKET

ZOM

ZOM

Zomedica Corp
AMEX
0.1320
+0.0007
+0.53%
Opening 10:26 04/24 EDT
OPEN
0.1316
PREV CLOSE
0.1313
HIGH
0.1321
LOW
0.1315
VOLUME
298.33K
TURNOVER
0
52 WEEK HIGH
0.2450
52 WEEK LOW
0.1200
MARKET CAP
129.35M
P/E (TTM)
-3.7500
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at ZOM last week (0415-0419)?
Weekly Report · 2d ago
Weekly Report: what happened at ZOM last week (0408-0412)?
Weekly Report · 04/15 09:46
Weekly Report: what happened at ZOM last week (0401-0405)?
Weekly Report · 04/08 09:47
ZOM Stock Earnings: Zomedica Beats Revenue for Q4 2023
Zomedica just reported results for the fourth quarter of 2023. The company reported revenue of $7.34 million. Zomedica reported earnings per share of -2.3 cents. This was 4.81% better than the analyst estimate for the quarter.
Investorplace · 04/02 00:53
Zomedica Achieves Record Revenue and Strong Growth
TipRanks · 04/01 21:37
Zomedica Q4 2023 GAAP EPS $(0.02), Sales $7.337M Beat $7.000M Estimate
Benzinga · 04/01 20:28
Zomedica reports Q4 results
Seeking Alpha · 04/01 20:15
Weekly Report: what happened at ZOM last week (0325-0329)?
Weekly Report · 04/01 09:47
More
About ZOM
Zomedica Corp. is a veterinary health company. The Company is engaged in creating products for horses, dogs, and cats by focusing on the unmet needs of clinical veterinarians. The Company's product portfolio includes diagnostics and medical devices that emphasize patient health and practice health. Its Diagnostics segment consists of TRUFORMA, VetGuardian, and TRUVIEW products. Its Therapeutic Devices segment consists of Assisi and PulseVet products. Its TRUFORMA platform comprises point-of-care diagnostic products for disease states in dogs, cats and horses, providing assays for use at the point-of-care that provide reference lab accuracy. Its TRUVIEW platform consists of the TRUVIEW digital cystoscopy instrument providing microscopic images and related pathology services which enable practitioners to receive a pathologist interpretation of the images. The Assisi Loop platform includes a series of products that use targeted pulsed electromagnetic field (tPEMF) therapy.

Webull offers Zomedica Corp stock information, including AMEX: ZOM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ZOM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ZOM stock methods without spending real money on the virtual paper trading platform.